The Terumo Group has established key sustainability activity themes to resolve issues related to healthcare, society, and the global environment, and is working to realize a sustainable society and …

Mar 5, 2026 · Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector (PDF 186.45 KB)

Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions.

Terumo is a global medical device company originating from Japan. We pursue reliable quality and technology to contribute to healthcare in more than 160 countries and regions around the globe.

Currently, the Terumo Group includes three companies that operate in over 160 countries and regions around the world, providing patients, a variety of medical settings, and the pharmaceutical industry …

Terumo Group’s target for reducing greenhouse gas emission in fiscal 2030 was approved to be aligned with the “1.5 degrees pathway” by the Science-Based Targets initiative.

Headquartered on the East Coast of the United States, in New Jersey, Terumo Medical Corporation is the central location for four divisions, notably Terumo Health Outcomes (THO), Terumo Medical …

Since its establishment in 1921, Terumo has been committed to contributing to patients and healthcare professionals. Under the unchanging Group Mission of “Contributing to Society through Healthcare,” …

Nuestra Historia Acerca de Terumo en Latinoamérica (ubicaciones) Información del Negocio Información del Negocio División TIS (Terumo Interventional Systems) División Neurovascular …

Terumo to deliver a presentation at the 44th J.P. Morgan Healthcare Conference, presented by our Chief Executive Officer, Hikaru Samejima (Monday, January 12, 2026 05:15 - 05:55 PM PST)